Literature DB >> 9164674

Defining a role for c-Myc in breast tumorigenesis.

S J Nass1, R B Dickson.   

Abstract

The proto-oncogene c-myc is commonly amplified and overexpressed in human breast tumors, and the tumorigenic potential of c-myc overexpression in mammary tissue has been confirmed by both in vitro and in vivo models of breast cancer. However, the mechanisms by which Myc promotes tumorigenesis are not well understood. Recent evidence indicates that Myc can promote cell proliferation as well as cell death via apoptosis. These studies provide new insight and impetus in defining a role for c-Myc in breast tumorigenesis and may point toward novel targets for breast cancer therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164674     DOI: 10.1023/a:1005858611585

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  18 in total

1.  Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor.

Authors:  Chunyu Wang; Julie Ann Mayer; Abhijit Mazumdar; Kirsten Fertuck; Heetae Kim; Myles Brown; Powel H Brown
Journal:  Mol Endocrinol       Date:  2011-08-11

2.  Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma.

Authors:  Lixing Zhan; Avi Rosenberg; Kenneth C Bergami; Min Yu; Zhenyu Xuan; Aron B Jaffe; Craig Allred; Senthil K Muthuswamy
Journal:  Cell       Date:  2008-11-28       Impact factor: 41.582

Review 3.  Gene therapy for carcinoma of the breast.

Authors:  M A Stoff-Khalili; P Dall; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-01-06       Impact factor: 5.987

4.  Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.

Authors:  N Aziz; H Cherwinski; M McMahon
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 5.  Myc and mammary cancer: Myc is a downstream effector of the ErbB2 receptor tyrosine kinase.

Authors:  N E Hynes; H A Lane
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

Review 6.  Molecular chemotherapy for breast cancer.

Authors:  A Patterson; A L Harris
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

Review 7.  Genes, chromatin, and breast cancer: an epigenetic tale.

Authors:  L M Mielnicki; H L Asch; B B Asch
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

8.  RNA sequencing of MCF-7 breast cancer cells identifies novel estrogen-responsive genes with functional estrogen receptor-binding sites in the vicinity of their transcription start sites.

Authors:  Ryonosuke Yamaga; Kazuhiro Ikeda; Kuniko Horie-Inoue; Yasuyoshi Ouchi; Yutaka Suzuki; Satoshi Inoue
Journal:  Horm Cancer       Date:  2013-03-23       Impact factor: 3.869

9.  The molecular genetics of breast cancer and targeted therapy.

Authors:  Rachel Suter; James A Marcum
Journal:  Biologics       Date:  2007-09

10.  Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.

Authors:  J Zhang; Y Li; Q Liu; W Lu; G Bu
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.